A simple nudge could boost shingles shots
NCT ID NCT06238726
First seen Aug 14, 2026 ยท Last updated Aug 14, 2026
Summary
This trial tests whether sending reminder messages to older adults before a doctor's appointment can increase the number who get the shingles vaccine. The study will compare different message styles to see which is most effective. Participants are adults aged 50 and older who have not yet received the Shingrix vaccine and have an upcoming primary care appointment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Behavioral intervention: reminder messages (via SMS, patient portal, email, or other) encouraging patients to ask about the Shingrix vaccine
- What this could lead to
- If effective, simple reminder messages could significantly increase shingles vaccination rates among older adults, reducing the burden of this painful condition.
- What could go wrong
- The trial is early and tests different message versions; not all may work. Also, reminders alone may not overcome other barriers to vaccination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHAVIOR, HEALTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Geisinger Clinic
Danville, Pennsylvania, 17822, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Health coaching in home visits may help moms shed baby weight and protect their hearts
- Meditation may reshape your brain, new scan study hints
- Can a simple text message save lives? new trial aims to boost colon cancer screening
- Texting patients and doctors boosts lifesaving screenings
- Women-Only heart classes aim to boost recovery and knowledge
- New shingles vaccine shows promise in Head-to-Head trial